Burroughs Wellcome Fund Archives
SCRIPS Symposium
Mar. 28, 2019—Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD.
Inaugural SCRIPS symposium set for March 21
Mar. 15, 2019—The inaugural SCRIPS symposium — Supporting Careers in Research for Interventional Physicians and Surgeons — will be held from 1-4 p.m. March 21 in 202 Light Hall.
Mother knows best
Jul. 2, 2018—The first demonstration of bacterial DNA in mammalian fetal intestinal tissue suggests that the mother’s microbiome moves into the fetal intestine.
Burroughs Wellcome Fund award expands opportunities for physician-scientists
Jun. 21, 2018—Vanderbilt University has received a five-year, $2.5-million Physician Scientist Institutional Award from the Burroughs Wellcome Fund to help bolster the dwindling number of active physician-scientists in the United States.
New BRET course offers introduction to data science
Jun. 21, 2018—Biomedical science trainees at Vanderbilt have a new career exploration option starting this fall — they can get a taste of what it means to be a “data scientist.” The Biomedical Research Education and Training (BRET) Office of Career Development’s ASPIRE Program received a Burroughs Wellcome Fund (BWF) grant to support a new ASPIRE Module...
New imaging approach offers unprecedented views of staph infection
Mar. 15, 2018—A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.
Risk of death in sickle cell disease
Feb. 22, 2017—Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.
Building the basement membrane
Nov. 21, 2016—Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues.
Detect and defend against pathogens
Nov. 4, 2015—Understanding factors, such as the receptor TLR9, that detect and defend against pathogens may lead to therapeutic approaches that promote an effective immune response to treat infections.
Study identifies C. diff toxin receptor, suggests new treatment approaches
Jun. 4, 2015—Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.
Cassat lands Burroughs Wellcome Fund award
Jul. 31, 2014—James Cassat, M.D., Ph.D., assistant professor of Pediatrics and Pathology, Microbiology and Immunology, has received a Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
Defusing ‘C. diff’ infection
Nov. 8, 2013—Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. difficile toxin, TcdB, induces rapid cell death of human colon cell lines and pig colonic...
